Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMK8PTH)

Drug Name
PRM-151 Drug Info
Indication
Disease Entry ICD 11 Status REF
Idiopathic pulmonary fibrosis CB03.4 Phase 2 [1]
Macular degeneration 9B78.3 Phase 2 [2]
Myelofibrosis 2A20.2 Phase 2 [1]
Polycythemia vera 2A20.4 Phase 2 [3]
Thrombocythemia 3B63 Phase 2 [3]
Cross-matching ID
TTD Drug ID
DMK8PTH

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neuronal pentraxin-2 (NPTX2) TTNJ5A6 NPTX2_HUMAN Modulator [2]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis. Drug News Perspect. 2010 Jun;23(5):305-15.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)